Cardio Triple-Combo Drugs To Get FDA Panel Review
This article was originally published in The Pink Sheet Daily
Fixed combinations of an anti-hypertensive drug, aspirin and a statin will be the subject of an upcoming Cardiovascular and Renal Drugs Advisory Committee meeting, although no specific product is included on the agenda.
You may also be interested in...
CDER-based program lead by Marta Sokolowska will also handle benzodiazepine and stimulants activities and consult on relevant application assessments.
A deputy center director position remains open and four new associate director positions were added over the last year.
As patients log device complaints for Mylan’s Advair Diskus generic Wixela Inhub, the agency is assessing whether additional reminders about the products’ differences are needed.